Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Shyamal Wahie"'
Autor:
Garry Meakin, R Ellis, Jennifer White, Hywel C Williams, Kim S Thomas, Rachel H. Haines, John R. Ingram, Andrew Wright, A Perways, Anthony Bewley, J. M. R. Goulding, J Azad, H Hamad, Jonathan M. Batchelor, Alan A Montgomery, Miriam Santer, Nick J. Levell, A Makrygeorgou, Adam Ferguson, S T Cheung, Shyamal Wahie, M. Ogboli, Wei Tan, Anne Rogers, Joanne R Chalmers, Maxine E Whitton, Jane Ravenscroft, Tracey Sach, Lelia Duley, Viktoria Eleftheriadou, A Rajasekaran, J Stainforth, B. Laguda
Background: Economic evidence for vitiligo treatments is absent. Objectives: To determine the cost-effectiveness of (i) handheld narrowband ultraviolet B (NB-UVB) and (ii) a combination of topical corticosteroid (TCS) and NB-UVB compared with TCS alo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::453264072e4e4a135d3f4fe169fe7960
Autor:
A Makrygeorgou, Viktoria Eleftheriadou, J. M. R. Goulding, Joanne R Chalmers, Hywel C Williams, Jennifer White, J Azad, H Hamad, B. Laguda, Jonathan M. Batchelor, Andrew Wright, Miriam Santer, Garry Meakin, M. Ogboli, J Stainforth, Anthony Bewley, Adam Ferguson, Jane Ravenscroft, Nick J. Levell, John R. Ingram, Perways Akram, R Ellis, A Rajasekaran, Lelia Duley, S T Cheung, Alan A Montgomery, Rachel H. Haines, Anne Rogers, Wei Tan, Kim S Thomas, Shyamal Wahie, Maxine E Whitton, Tracey Sach
Publikováno v:
The British Journal of Dermatology
Background: Evidence for the effectiveness of vitiligo treatments is limited. Objectives: To determine the effectiveness of (i) handheld narrowband UVB (NB-UVB) and (ii) a combination of potent topical corticosteroid (TCS) and NB-UVB, compared with T
Autor:
Hywel L Cooper, Kaspar Torz, Jonathan Barker, Zsuzsa Bata-Csorgo, Tejus Dasandi, Charlotte Chaloner, Helen J. Lachmann, R Parslew, Natashia Benzian-Olsson, Plum study team, H. McAteer, Sulev Kõks, F. Meynell, Richard B. Warren, Victoria Cornelius, Prakash Patel, Shyamal Wahie, Külli Kingo, Catherine H. Smith, Christopher E.M. Griffiths, Adrian Tanew, Andrew Wright, Alexander A. Navarini, Andrew Pink, Ulrich Mrowietz, Suzie Cro, A. David Burden, Riccardo G. Borroni, Francesca Capon, Nick J. Reynolds, Hannes Trattner, Nick Dand
Publikováno v:
JAMA Dermatology
JAMA Dermatol
JAMA Dermatol
Key Points Question Are clinical and demographic factors associated with the severity of palmoplantar pustulosis? Findings In a cross-sectional study of 203 patients in the UK, the Palmoplantar Pustulosis Psoriasis Area Severity Index score was signi
Autor:
Richard B. Warren, Christopher E.M. Griffiths, Karien Bloem, Jonathan Barker, Michael Duckworth, Teresa Tsakok, Ruth Murphy, Annick de Vries, Nina Wilson, Nick Dand, Joseph F. Standing, Floris C. Loeff, David Baudry, A. David Burden, Angela Pushpa-Rajah, Ali Alsharqi, Gabrielle Becher, Shan Pan, Theo Rispens, Shyamal Wahie, Andrew Wright, Catherine H. Smith, Nick J. Reynolds, Deborah D. Stocken
Publikováno v:
Tsakok, T, Wilson, N, Dand, N, Loeff, F C, Bloem, K, Baudry, D, Duckworth, M, Pan, S, Pushpa-Rajah, A, Standing, J F, De Vries, A, Alsharqi, A, Becher, G, Murphy, R, Wahie, S, Wright, A, Griffiths, C E M, Reynolds, N J, Barker, J, Warren, R B, Burden, A D, Rispens, T, Stocken, D & Smith, C 2019, ' Association of Serum Ustekinumab Levels with Clinical Response in Psoriasis ', JAMA dermatology, vol. 155, no. 11, pp. 1235-1243 . https://doi.org/10.1001/jamadermatol.2019.1783
JAMA dermatology, 155(11), 1235-1243. American Medical Association
JAMA dermatology, 155(11), 1235-1243. American Medical Association
Importance: High-cost biologic therapies have transformed the management of immune-mediated inflammatory diseases. To optimize outcomes and reduce costs, dose adjustment informed by measurement of circulating drug levels has been shown to be effectiv
Autor:
John R. Ingram, H K Bell, Gudula Kirtschig, B Walker, Fiona Antony, M Walsh, Eva-B. Bröcker, Ingrid Salvary, J Wee, Emilia Duarte-Williamson, H Santander, Kathy Taghipour, David Gawkrodger, Enno Schmidt, Sam Gibbs, Alison M Layton, Michael Sticherling, J Adams, M Vatve, Joanne R Chalmers, Hywel C Williams, Fiona Craig, S Blackford, A Carmichael, Walter Bottomley, Adzura Azam, Chris Lovell, Karen E. Harman, Margaret Childs, Alexander Vincent Anstey, K. Hussain, Marinella Nik, C Günthert, A. Chapman, N. van Beek, Andrew M Wright, Rainer Hügel, C Barnard, Indre Verpetinske, K Davies, Thomas A. Luger, A Omerod, Karen Gibbon, Alex Waters, V Akhras, Robert Charles-Holmes, Shyamal Wahie, John C. English, James Mason, R.R. Coelho, Girish Khandubhai Patel, Robert Ellis, Jane C. Sterling, A Lloyd Lavery, Thomas R. Godec, Fenella Wojnarowska, Jane Ravenscroft, Richard Groves, H Malhomme, Kerstin Steinbrink, Andrew J. Nunn, Regine Gläser, Emma Veysey, Adam Ferguson, V Lewis, Diane Whitham, V Venning, M Westmoreland, G Wong, Chris Bower, N. Hepburn, C Thomas, P J Hampton, R. Wachsmuth, Andrew Ilchyshyn, Nick J. Levell, M G S Dunnill, S. Walton, R Rallan
Publikováno v:
Lancet (London, England)
BACKGROUND: Bullous pemphigoid is a blistering skin disorder with increased mortality. We tested whether a strategy of starting treatment with doxycycline gives acceptable short-term blister control while conferring long-term safety advantages over s
Publikováno v:
Lupus. 27(5)
Background Hydroxychloroquine (HCQ), a 4-aminoquinolone antimalarial, is regarded as the oral therapy of choice for cutaneous and systemic lupus erythematosus (SLE). It is also licensed for rheumatoid arthritis (RA). Studies of HCQ-treated patients w
Autor:
SJ Meggitt, Mary M. Carr, Angela Drummond, Ann K. Daly, Stephen K. Jones, Nick J. Reynolds, Shyamal Wahie, S. Natarajan, Catherine H. Smith, Heather J. Cordell, Andrew J. Carmichael, Mark Goodfield, C. R. Lovell
Publikováno v:
Journal of Investigative Dermatology. 131:1981-1986
The recommended systemic therapy of choice for discoid lupus erythematosus (DLE) is the 4-aminoquinolone antimalarial hydroxychloroquine. There is limited published information on the likelihood of clinical response and, in particular, what factors i
Publikováno v:
British Journal of Dermatology. 162:1030-1037
Summary Background Discoid lupus erythematosus (DLE) is a disfiguring inflammatory skin disease. There is no specific tool for measuring disease severity. Objectives To determine the features needed in a score measuring activity and damage in DLE and
Autor:
Shyamal Wahie, SJ Meggitt
Publikováno v:
The British journal of dermatology. 169(3)
Summary Background The recommended first-line oral therapy for discoid lupus erythematosus (DLE) is the antimalarial hydroxychloroquine. To the best of our knowledge, there is no published information regarding the long-term (i.e. > 6 months) respons
Autor:
Konstantinos Douroudis, Ravi Ramessur, Ines A. Barbosa, David Baudry, Michael Duckworth, Caroline Angit, Francesca Capon, Raymond Chung, Charles J. Curtis, Paola Di Meglio, Jonathan M.R. Goulding, Christopher E.M. Griffiths, Sang Hyuck Lee, Satveer K. Mahil, Richard Parslew, Nick J. Reynolds, Alexa R. Shipman, Richard B. Warren, Zenas Z.N. Yiu, Michael A. Simpson, Jonathan N. Barker, Nick Dand, Catherine H. Smith, Ian Evans, Ruth Murphy, Tess McPherson, Elise Kleyn, Philip Laws, Gabrielle Becher, Anthony Bewley, Amir Rashid, Oras Alabas, Simon Morrison, Shehnaz Ahmed, Eleanor Pearson, Josh Richards, Teena Mackenzie, Brian Kirby, David Burden, Linda Lawson, Kathleen McElhone, Anthony Ormerod, Caroline Owen, Nadia Aldoori, Mahmud Ali, Alex Anstey, Fiona Antony, Charles Archer, Suzanna August, Periasamy Balasubramaniam, Kay Baxter, Alexandra Bonsall, Victoria Brown, Katya Burova, Aamir Butt, Mel Caswell, Sandeep Cliff, Mihaela Costache, Sharmela Darne, Emily Davies, Claudia DeGiovanni, Trupti Desai, Bernadette DeSilva, Victoria Diba, Eva Domanne, Harvey Dymond, Caoimhe Fahy, Leila Ferguson, Maria-Angeliki Gkini, Alison Godwin, Fiona Hammonds, Sarah Johnson, Teresa Joseph, Manju Kalavala, Mohsen Khorshid, Liberta Labinoti, Nicole Lawson, Alison Layton, Tara Lees, Nick Levell, Helen Lewis, Calum Lyon, Sandy McBride, Sally McCormack, Kevin McKenna, Serap Mellor, Paul Norris, Urvi Popli, Gay Perera, Nabil Ponnambath, Helen Ramsay, Aruni Ranasinghe, Saskia Reeken, Rebecca Rose, Rada Rotarescu, Ingrid Salvary, Kathy Sands, Tapati Sinha, Simina Stefanescu, Kavitha Sundararaj, Kathy Taghipour, Michelle Taylor, Michelle Thomson, Joanne Topliffe, Roberto Verdolini, Rachel Wachsmuth, Martin Wade, Shyamal Wahie, Sarah Walsh, Shernaz Walton, Louise Wilcox, Andrew Wright
Publikováno v:
BADBIR Study Group 2021, ' Differences in Clinical Features and Comorbid Burden between HLA-C∗06:02 Carrier Groups in >9,000 People with Psoriasis ', The Journal of investigative dermatology . https://doi.org/10.1016/j.jid.2021.08.446
The identification of robust endotypes—disease subgroups of clinical relevance—is fundamental to stratified medicine. We hypothesized that HLA-C∗06:02 status, the major genetic determinant of psoriasis, defines a psoriasis endotype of clinical